<?xml version="1.0" encoding="UTF-8"?>
<p>HCV prevalence in Egypt ranged from 4.3% to 100%, with a median of 66.2%. The pooled mean prevalence in all populations with LRDs was 58.8% (95% CI, 51.5%‐66.0%). The pooled mean prevalence was lowest in patients with viral hepatitis (17.6%; 95% CI, 10.4%‐26.1%) and highest in patients with liver disease (74.9%; 95% CI, 67.3%‐81.8%), followed closely by patients with hepatocellular carcinoma (HCC) (74.8%; 95% CI, 68.2%‐80.9%).</p>
